ENTITY

Protalix BioTherapeutics (PLX US)

14
Analysis
Health Care • United States
Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.
more
Exchange Announcement • 12 Aug 2026 19:40

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 12 Aug 2026 19:09

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 12 Aug 2026 18:59

Current Report (Form 8-K | Period ending 2026-08-12)

Exchange Announcement • 26 Jun 2026 04:30

Current Report (Form 8-K | Period ending 2026-06-25)

Exchange Announcement • 21 May 2026 19:03

Current Report (Form 8-K | Period ending 2026-05-21)

x